Abbas, Leslie T.

HRN: 21-41-01  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2022
CEFUROXIME 500MG (TAB)
05/30/2022
06/05/2022
ORAL
500mg
BID
S/P NSVD W/ Repair Of Perineal Laceration
Waiting Final Action 

Indication:      Type of Infection:      Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: